Search Results - "Brito‐Dellan, Norman"

Refine Results
  1. 1

    MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy by Elad, Sharon, Cheng, Karis Kin Fong, Lalla, Rajesh V., Yarom, Noam, Hong, Catherine, Logan, Richard M., Bowen, Joanne, Gibson, Rachel, Saunders, Deborah P., Zadik, Yehuda, Ariyawardana, Anura, Correa, Maria Elvira, Ranna, Vinisha, Bossi, Paolo, Arany, Praveen, Al‐Azri, Abdul Rahman, Blijlevens, Nicole, Hovan, Allan, Fregnani, Eduardo, Fulton, Janet, Gueiros, Luiz Alcino, Rouleau, Tanya, Coller, Janet K., Al‐Dasooqi, Noor, Wardill, Hannah, Ameringer, Suzanne, Antunes, Héliton Spindola, Bateman, Emma H., Bektas, Kivanc, Bensadoun, René‐Jean, Ten Bohmer, K., Brito‐Dellan, Norman, Castillo, Daniel, Chiang, Karen, de Mooij, Charlotte, Eilers, June, Epstein, Joel, Galiti, Dimitra, Fall‐Dickson, Jane M., Gobbo, Margherita, Issa Hazboun, Hanan, Jensen, Siri Beier, Johansen, Jorgen, Joy, Jamie, Joy, K., Kandwal, Abhishek, Kataoka, Tomoko, Keefe, Dorothy, Loprinzi, Charles L., Lubart, Rachel, Skripnik Lucas, Anna, Majorana, Alessandra, Mayo, Bronwen, de Mooij, Charlotte, Mori, Takehiko, Nair, Raj G., Nasr, Narmin, Nicolatou‐Galitis, Ourania, Ottaviani, Giulia, Migliorati, Cesar, Pentenero, Monica, Porcello, Lorraine, Peterson, Douglas, Potting, Carin, Raber‐Durlacher, Judith, van Sebille, Ysabella Z. A., Soga, Yoshihiko, Sonis, Stephen, Stringer, Andrea M., Thorpe, Daniel, Tilly, Vanessa, Tissing, Wim, Toro, Juan J., Treister, Nathaniel Simon, Vaddi, Anusha, Weikel, Dianna, van de Wetering, Marianne, Zur, Eyal

    Published in Cancer (01-10-2020)
    “…Background Mucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the…”
    Get full text
    Journal Article
  2. 2

    Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT) by Tsoukalas, Nikolaos, Brito-Dellan, Norman, Font, Carme, Butler, Taylor, Rojas-Hernandez, Cristhiam M., Butler, Thomas, Escalante, Carmen

    Published in Supportive care in cancer (01-10-2022)
    “…Cancer patients have an increased risk of developing venous thromboembolic events. Anticoagulation management includes prophylactic or therapeutic doses of low…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Thrombosis, cancer, and COVID-19 by Brito-Dellan, Norman, Tsoukalas, Nikolaos, Font, Carme

    Published in Supportive care in cancer (01-10-2022)
    “…Cancer and coronavirus disease 2019 (COVID-19) have unusual similarities: they both result in a markedly elevated risk of thrombosis, exceptionally high…”
    Get full text
    Journal Article
  5. 5

    Toxicities of the anti-PD-1 immune checkpoint antibody nivolumab in the acute inpatient setting by Brito-Dellan, Norman

    Published in Journal of clinical oncology (09-10-2016)
    “…Abstract only 227 Background: Knowledge of immune-system regulation led to the discovery of immune checkpoints molecules, which have demonstrated anti-tumor…”
    Get full text
    Journal Article
  6. 6

    Risks, diagnosis, and management of recurrent cancer-associated thrombosis (CAT): a narrative review by Dickson, Kodwo, Koom-Dadzie, Kwame, Brito-Dellan, Norman, Escalante, Carmen

    Published in Supportive care in cancer (01-10-2022)
    “…This paper aims to provide a narrative review of the risks, diagnosis, and management of recurrent venous thromboembolism (VTE) in cancer patients. There is an…”
    Get full text
    Journal Article
  7. 7

    Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care by Laguna, Juan Carlos, Cooksley, Tim, Ahn, Shin, Tsoukalas, Nikolaos, Oo, Thein Hlaing, Brito-Dellan, Norman, Esposito, Francis, Escalante, Carmen, Font, Carme

    Published in Supportive care in cancer (01-10-2022)
    “…Central venous access devices (CVADs) including central venous catheters and peripherally inserted central catheters (PICCs) are essential in the treatment of…”
    Get full text
    Journal Article
  8. 8

    Complexity and clinical significance of drug-drug interactions by Tsoukalas, Nikolaos, Brito-Dellan, Norman, Font, Carme, Butler, Taylor, Rojas-Hernandez, Cristhiam M, Butler, Thomas, Escalante, Carmen

    Published in Supportive care in cancer (01-10-2022)
    “…Cancer patients have an increased risk of developing venous thromboembolic events. Anticoagulation management includes prophylactic or therapeutic doses of low…”
    Get full text
    Journal Article
  9. 9

    Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies by Font, Carme, de Herreros, Marta García, Tsoukalas, Nikolaos, Brito-Dellan, Norman, Espósito, Francis, Escalante, Carmen, Oo, Thein Hlaing

    Published in Supportive care in cancer (01-10-2022)
    “…Thrombotic microangiopathy (TMA) is a syndrome that encompasses a group of disorders defined by the presence of endothelial damage leading to abnormal…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Opioid and Adjuvant Analgesics: Compared and Contrasted by Khan, Mohammed Ilyas Ahmed, Walsh, Declan, Brito-Dellan, Norman

    “…An adjuvant (or co-analgesic) is a drug that in its pharmacological characteristic is not necessarily primarily identified as an analgesic in nature but that…”
    Get full text
    Journal Article
  15. 15

    Utilizing electronic technologies to measure patient-reported outcomes (PRO) assessment completion time by Brito-Dellan, Norman, Lam, Tony, Richardson, Marsha N., Manzullo, Ellen F., Kallen, Michael, Yang, DerShung, Haas, Niina Mari, Escalante, Carmelita P.

    Published in Journal of clinical oncology (09-10-2016)
    “…Abstract only 69 Background: Patient-reported outcomes (PROs) contribute to the assessment and treatment of cancer-related fatigue (CRF). Paper-based symptom…”
    Get full text
    Journal Article
  16. 16

    Safer transitions of care at a major cancer center: The emergency center to hospitalist experience by Banala, Srinivas, Gonzalez, Carmen E., Brito-Dellan, Norman, Rubio, David, Ait Aiss, Mohamed, Rice, Terry, Chen, Karen, Bodurka, Diane C., Escalante, Carmelita P.

    Published in Journal of clinical oncology (01-03-2016)
    “…Abstract only 247 Background: Failures in communication lead to serious medical errors particularly during transitions of care. A standardized handoff of…”
    Get full text
    Journal Article
  17. 17

    Meta-analysis: Risk of congestive heart failure (CHF) in selected targeted agents by Escalante, Carmelita P., Elting, Linda S., Halm, Josiah, Zalpour, Ali, Bossi, Paolo, Yusuf, SWamique, Brito-Dellan, Norman, Sahai, Sunil, Bhadriraju, Satish, Rouleau, Tanya, Chang, Yuchia

    Published in Journal of clinical oncology (10-10-2015)
    “…Abstract only 64 Background: Congestive heart failure (CHF) is among the most serious cardiovascular side effects of targeted agents (TA) impacting the…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi study by Keefe, Dorothy, Blijlevens, Nicole, Cheung, Yin Ting, Epstein, Joel, Kauark-Fontes, Elisa, Finkelstein, Joel, Flato, Adriana Do Socorro Lima, Gruza, Amanda, El Maghrabi, Amr, Blazy, Anne, Lynge Pedersen, Anne Marie, Al-Azri, Abdul Rahman, Bonomo, Pierluigi, Spekssnijder, Caroline, Anderson, Carryn, Loprinzi, Charles, Choi, Ying Chu, Schmeel, Leonard, Nagano, Cibele, Franco, Maria Coeli, Patrick, Carolyn, Goldemberg, Daniel Cohen, Sundaresan, Daniel, Travassos, Daphine, Ribeiro, Daniela, De Bortolli, Juliane, Weikel, Dianna, Galiti, Dimitra, Djordjevic, Fedja, Fonseca, Douglas, Passos, Januaria, Uezu, Katia, Yeoh, Keng, Shatokhina, Evgeniya, Adebayo-Olojo, Esther, Somogyi-Ganss, Eszter, Freytes, Cesar, Caro, Gemma, Potter, Gleidston, Hoeberechts, Gulbin, Howarth, Gordon, Wardill, Hannah, Ullgren, Helena, Antunes, Heliton Spindola, Illarramendi, Jorge, Kalif, Isadora, Coller, Janet, Beck-Mannagetta, Johann, Mougeot, Jean-Luc, Wu, Jonn, Palma, Patricio, Raber-Durlacher, Judith, Jasper, Juliana, Lima, Karol Sartori, Skallsjö, Kristina, Gueiros, Luiz, Agatti, Larissa, Braun, Liliana, McKeage, Lucy, Souza, Maíra, Minamisako, Mariana, Andrade, Marco, Vitor, Mariana, Markova, Alina, Neves, Marta, Brennan, Michael, Nakamura, Michio, Rossi, Camila, Stokman, Monique, Taleghani, Maryam, Tanda, Naoko, Nasr, Narmin, Serrano, Verônica, Blijlevens, Nicole, Yarom, Noam, Lemenchick, Olivia, Mendes, Ondina, Nicolatou-Galitis, Ourania, Santos, Paulo Sérgio, Fritz, Peter, Gardner, Pamela, Nair, Raj, Abdalla-Aslan, Ragda, Mendes, Rui Amaral, Bensadoun, Rene-Jean, Gunathilake, Sahani, Barbosa, Luciana S Barbosa, Elad, Sharon, Cantoreggi, Sergio, Janine Tam, Shu Yie, Sperandio, Felipe, Reese, Sandra, Roser, Steven, Polvora, Tabata Santos, Wain, Taylor, Brown, Timothy, Ferreira, Thalyta Amanda, Kelly, Thomas, Sarmento, Viviane, Matsuda, Yuhei

    Published in EClinicalMedicine (01-07-2024)
    “…Mucositis is a common and highly impactful side effect of conventional and emerging cancer therapy and thus the subject of intense investigation. Although…”
    Get full text
    Journal Article